相关实验视频
Updated: Sep 17, 2025

09:27
Protein Crystallization for X-ray Crystallography
Published on: January 16, 2011
63.9K
聚乙烯醇诱导的酶晶体形态调节:从六角到花状结构
Aoran Xiong1, Yuxi Zhen1, Xiaojie Zhou1
1State Key Laboratory of Chemical Engineering, East China University of Science and Technology, Shanghai 200237, China.
International journal of biological macromolecules
|June 27, 2025
概括
聚乙醇 (PVA) 通过与蛋白质侧链相互作用来控制蛋白质晶体形态,从而使量身定制的晶体形状能够改善结构生物学和药物开发. 这种方法提高了各种蛋白质的衍射质量.
科学领域:
- 结构生物学 结构生物学
- 生物物理学的生物物理.
- 材料科学 材料科学 材料科学
背景情况:
- 蛋白质晶体形态学对结构生物学和药物开发中的衍射质量和分析精度产生了重大影响.
- 目前用于精确控制蛋白质晶体形态的方法有限.
研究的目的:
- 研究使用聚乙烯醇 (PVA) 作为选择性添加剂来控制蛋白质晶体形态.
- 探索蛋白质晶体中PVA诱导的形态变化的潜在机制.
主要方法:
- 酶和蛋白酶K结晶实验,使用不同度的PVA.
- 使用显微镜分析晶体形态.
- 通过光谱测定蛋白质二次结构变化 (例如,α-螺旋,β-片含量).
- 分子动力学 (MD) 模拟以阐明PVA-蛋白相互作用和生长机制.
主要成果:
- 通过调整其质量分数,PVA成功诱导了酶晶体 (六角到板状和花状的形状) 的显著形态转换.
- 聚乙烯的多基结构促进了与酶的向相互作用,减少了蛋白质聚合并改变了晶体表面的分子排列.
- 观察到酶的形状变化,包括减少的α螺旋和增加的β片含量,而不会影响衍射质量 (1.93 Å对于酶).
- MD模拟证实了PVA在修改酶稳定性,分子间结合和促进异型生长方面的作用.
- 此外,PVA还控制了蛋白酶K晶体形态,产生了高衍射质量 (1.72 Å).
结论:
- 通过与蛋白质功能组的特定相互作用,PVA作为一种有效的添加剂,可以精确控制蛋白质晶体形态.
- 该方法为获得具有结构和发育应用所需形态的高质量蛋白质晶体提供了一种多功能方法.
- 通过PVA控制晶体习惯,为推进结构生物学和药物发现提供了有价值的策略.
相关概念视频
Polymer Classification: Crystallinity
3.1K
Unlike ionic or small covalent molecules, polymers do not form crystalline solids due to the diffusion limitations of their long-chain structures. However, polymers contain microscopic crystalline domains separated by amorphous domains.
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
3.1K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
406
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
406
Polymer Classification: Stereospecificity
2.7K
Polymerization generates chiral centers along the entire backbone of a polymer chain. Accordingly, the stereochemistry of the substituent group has a significant effect on polymer properties. Polymers formed from monosubstituted alkene monomers feature chiral carbons at every alternate position in the polymer backbone. Relative to the predominant orientation of substituents at the adjacent chiral carbons, the polymer can exist in three different configurations: isotactic, syndiotactic, and...
2.7K

